Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

4.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K
Embryonic Stem Cells00:58

Embryonic Stem Cells

25.8K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
25.8K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

8.4K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.4K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

1.9K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Verminous mastitis caused by <i>Cephalobus cubaensis</i> infection in a mare.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·2026
Same author

Development and Validation of Real-Time PCR for Detecting Anaplasma bovis-Like Agent in Dermacentor spp. Ticks.

Emerging infectious diseases·2026
Same author

Immunophenotyping challenges in the diagnosis of NK-LGLL.

Blood advances·2026
Same author

Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Blood cancer journal·2026
Same author

A humanized engineered heart tissue platform for cardiotoxicity assessment.

Stem cell reports·2026
Same author

Feasibility and safety of cellular therapy for in-utero repair of myelomeningocele (CuRe Trial): a first-in-human, phase 1, single-arm study.

Lancet (London, England)·2026

Related Experiment Video

Updated: May 1, 2026

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells
06:53

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Published on: January 13, 2023

3.9K

Natural killer cell subsets differentially reject embryonic stem cells based on licensing.

Jessica Perez-Cunningham1, Erik Ames, Rachel C Smith

  • 11 Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, CA. 2 Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, CA. 3 Stem Cell Program and Institute for Regenerative Cures, University of California, Davis, Sacramento, CA. 4 Address correspondence to: William J. Murphy, Ph.D., Department of Dermatology, University of California, Davis School of Medicine, IRC-Suite 1630, 2921 Stockton Blvd. Sacramento, CA 95817.

Transplantation
|April 8, 2014
PubMed
Summary

Natural killer (NK) cells reject embryonic stem cells (ESCs). NK cell licensing, particularly via NKG2D, influences this rejection, suggesting its importance for successful stem cell therapies.

More Related Videos

Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs
09:02

Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs

Published on: April 23, 2013

15.9K
Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.0K

Related Experiment Videos

Last Updated: May 1, 2026

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells
06:53

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Published on: January 13, 2023

3.9K
Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs
09:02

Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs

Published on: April 23, 2013

15.9K
Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.0K

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Embryonic stem cells (ESCs) hold therapeutic promise but face immune rejection.
  • Natural killer (NK) cells are key immune mediators in stem cell rejection.
  • The specific role of NK cell licensing in ESC rejection remains unclear.

Purpose of the Study:

  • To investigate the role of NK cells and NK cell licensing in embryonic stem cell (ESC) rejection.
  • To identify mechanisms by which NK cells mediate ESC rejection.

Main Methods:

  • Cytotoxicity assays using mouse/human ESCs and species-matched NK cells.
  • In vivo transplantation of mouse ESCs into allogeneic recipients with NK cell subset depletion.
  • Analysis of ESC engraftment using bioluminescent imaging.
  • In vitro blocking of NKG2D to assess its role in NK cell-mediated killing.

Main Results:

  • Depletion of all NK cells significantly increased ESC engraftment, confirming their role in rejection.
  • Differential ESC engraftment observed upon depletion of specific NK cell subsets (Ly49C/I, Ly49G2), highlighting the impact of NK cell licensing.
  • Blocking NKG2D reduced NK cell-mediated killing of mouse ESCs, indicating its involvement in the rejection process.

Conclusions:

  • Inhibitory Ly49 expression on NK cells correlates with their capacity to kill murine ESCs via an NKG2D-dependent mechanism.
  • Licensed NK cells play a critical role in the rejection of allogeneic ESCs.
  • The presence of licensed NK cells is likely crucial for the success of stem cell transplantation in humans.